Applying sparse coding to surface multivariate tensor-based morphometry to predict future cognitive decline
Alzheimer's disease (AD) is a progressive brain disease. Accurate diagnosis of AD and its prodromal stage, mild cognitive impairment, is crucial for clinical trial design. There is also growing interests in identifying brain imaging biomarkers that help evaluate AD risk presymptomatically. Here...
Saved in:
| Published in: | Proceedings (International Symposium on Biomedical Imaging) Vol. 2016; pp. 646 - 650 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Conference Proceeding Journal Article |
| Language: | English |
| Published: |
United States
IEEE
01.04.2016
|
| Subjects: | |
| ISSN: | 1945-7928, 1945-8452 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Alzheimer's disease (AD) is a progressive brain disease. Accurate diagnosis of AD and its prodromal stage, mild cognitive impairment, is crucial for clinical trial design. There is also growing interests in identifying brain imaging biomarkers that help evaluate AD risk presymptomatically. Here, we applied a recently developed multivariate tensor-based morphometry (mTBM) method to extract features from hip-pocampal surfaces, derived from anatomical brain MRI. For such surface-based features, the feature dimension is usually much larger than the number of subjects. We used dictionary learning and sparse coding to effectively reduce the feature dimensions. With the new features, an Adaboost classifier was employed for binary group classification. In tests on publicly available data from the Alzheimers Disease Neuroimaging Initiative, the new framework outperformed several standard imaging measures in classifying different stages of AD. The new approach combines the efficiency of sparse coding with the sensitivity of surface mTBM, and boosts classification performance. |
|---|---|
| Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Conference-1 ObjectType-Feature-3 content type line 23 SourceType-Conference Papers & Proceedings-2 ObjectType-Article-1 ObjectType-Feature-2 The research was supported in part by NIH (R21AG043760, R21AG049216, R01AG031581, P30AG19610), NSF (DMS-1413417, IIS-1421165) and Arizona Alzheimer’s Disease Consortium (ADHS14-052688). Funded in part by NIH ENIGMA Center grant U54EB020403, supported by the Big Data to Knowledge (BD2K) Centers of Excellence program. |
| ISSN: | 1945-7928 1945-8452 |
| DOI: | 10.1109/ISBI.2016.7493350 |